1. Australian Institute of Health and Welfare . Australia’s health 2018. Australia’s health series no. 16. AUS 221. Canberra: AIHW, 2018.
Google Scholar2. Bates, DW, Cullen, DJ, Laird, N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 29–34.
Google Scholar | Crossref | Medline | ISI3. Davis, P . Adverse events in New Zealand public hospitals I: occurrence and impact. N Z Med J 2002; 115: U271.
Google Scholar | Medline | ISI4. Leape, LL, Brennan, TA, Laird, N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377–384.
Google Scholar | Crossref | Medline | ISI5. Wilson, RM, Runciman, WB, Gibberd, RW, et al. The quality in Australian health care study. Med J Aust 1995; 163: 458–471.
Google Scholar | Crossref | Medline | ISI6. Budnitz, DS, Lovegrove, MC, Shehab, N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365: 2002–2012.
Google Scholar | Crossref | Medline | ISI7. Roughead, L, Semple, S, Rosenfeld, E. Literature review: medication safety in Australia. Sydney: Australian Commission on Safety and Quality in Health Care, 2013.
Google Scholar8. Roughead, EE, Semple, JS, Rosenfeld, JE. The extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia. Int J Evid Based Healthc 2016; 14: 113–122.
Google Scholar | Crossref | Medline | ISI9. World Health Organization . The third WHO global patient safety challenge: medication without harm, https://www.who.int/patientsafety/medication-safety/en/ (2019, accessed 29 August 2019).
Google Scholar10. Pharmaceutical Society of Australia . Medicine safety to be the 10th National Health Priority area, https://www.psa.org.au/ (2019, accessed 30 July 2020).
Google Scholar11. The Hon Greg Hunt MP . Doorstop interview about the COAG health ministers meeting, https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/doorstop-interview-about-the-coag-health-ministers-meeting (2019, accessed 30 July 2020).
Google Scholar12. Australian Commission on Safety and Quality in Health Care . APINCHS classification of high risk medicines, https://www.safetyandquality.gov.au/our-work/medication-safety/high-risk-medicines/apinchs-classification-high-risk-medicines (2019, accessed 8 November 2019).
Google Scholar13. Australian Commission on Safety and Quality in Health Care . High risk medicines, https://www.safetyandquality.gov.au/our-work/medication-safety/high-risk-medicines (2019, accessed 12 December 2019).
Google Scholar14. Institute for Safe Medication Practices . High-alert medications in acute care settings, https://www.ismp.org/recommendations/high-alert-medications-acute-list (2018, accessed 10 September 2019).
Google Scholar15. Clinical Excellence Commission . High-risk medicines, http://www.cec.health.nsw.gov.au/patient-safety-programs/medication-safety/high-risk-medicines/A-PINCH (2019, accessed 8 November 2019).
Google Scholar16. Australian Institute of Health and Welfare . Medicines for cardiovascular disease. Cat. no. CVD 80. Canberra: AIHW, 2017.
Google Scholar17. Holbeach, E, Yates, P. Prescribing in the elderly. Aust Fam Physician 2010; 39: 728–733.
Google Scholar | Medline | ISI18. Chew, DP, Scott, IA, Cullen, L, et al. National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016. Heart Lung Circ 2016; 25: 895–951.
Google Scholar | Crossref | Medline19. Ali Raza, J, Movahed, A. Use of cardiovascular medications in the elderly. Int J Cardiol 2002; 85: 203–215.
Google Scholar | Crossref | Medline20. Ruiz, B, Garcia, M, Aguirre, U, et al. Factors predicting hospital readmissions related to adverse drug reactions. Eur J Clin Pharmacol 2008; 64: 715–722.
Google Scholar | Crossref | Medline | ISI21. Wang, Y, Singh, S, Bajorek, B. Old age, high risk medication, polypharmacy: a ‘trilogy’ of risks in older patients with atrial fibrillation. Pharm Pract (Granada) 2016; 14: 706.
Google Scholar | Crossref | Medline22. Paradissis, C, Coombes, ID, Donovan, P, et al. The type and incidence of adverse drug events in ageing medical inpatients and their effect on length of hospital stay. J Pharm Pract Res 2017; 47: 347–354.
Google Scholar | Crossref23. Falconer, N, Barras, M, Abdel-Hafez, A, et al. Prioritising patients at high-risk of medication harm: Development and validation of risk prediction models [dissertation]. University of Queensland, Brisbane, Australia, 2019.
Google Scholar24. Falconer, N, Barras, M, Martin, J, et al. Defining and classifying terminology for medication harm: a call for consensus. Eur J Clin Pharmacol 2019; 75: 137–145.
Google Scholar | Crossref | Medline25. Australian medicines handbook online [Internet] . Adelaide (S. Australia): Australian Medicines Handbook Pty Ltd, 2020. Cardiovascular drugs, https://amhonline.amh.net.au/chapters/cardiovasculardrugs?menu=banner (2020, accessed 30 July 2020).
Google Scholar26. Guerrouij, M, Uppal, CS, Alklabi, A, et al. The clinical impact of bleeding during oral anticoagulant therapy: assessment of morbidity, mortality and post-bleed anticoagulant management. (Report). J Thromb Thrombolysis 2011; 31: 419.
Google Scholar | Crossref | Medline27. Piazza, G, Nguyen, TN, Cios, D, et al. Anticoagulation-associated adverse drug events. Am J Med 2011; 124: 1136–1142.
Google Scholar | Crossref | Medline28. Budnitz, DS, Shehab, N, Kegler, SR, et al. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007; 147: 755–765.
Google Scholar | Crossref | Medline | ISI29. Chan, M, Nicklason, F, Vial, J. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199–205.
Google Scholar | Crossref | Medline | ISI30. Hallas, J, Gram, LF, Grodum, E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 61–68.
Google Scholar | Crossref | Medline | ISI31. McDonnell, PJ, Jacobs, MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36: 1331–1336.
Google Scholar | SAGE Journals | ISI32. Mjorndal, T, Boman, MD, Hagg, S, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 2002; 11: 65–72.
Google Scholar | Crossref | Medline | ISI33. Onder, G, Pedone, C, Landi, F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962–1968.
Google Scholar | Crossref | Medline | ISI34. Pirmohamed, M, James, S, Meakin, S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15–19.
Google Scholar | Crossref | Medline35. Wawruch, M, Zikavska, M, Wsolova, L, et al. Adverse drug reactions related to hospital admission in Slovak elderly patients. Arch Gerontol Geriatr 2009; 48: 186–190.
Google Scholar | Crossref | Medline36. Kongkaew, C, Noyce, PR, Ashcroft, DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008; 42: 1017–1025.
Google Scholar | SAGE Journals | ISI37. Gustafsson, M, Sjolander, M, Pfister, B, et al. Drug-related hospital admissions among old people with dementia. Eur J Clin Pharmacol 2016; 72: 1143–1153.
Google Scholar | Crossref | Medline38. Runciman, WB, Roughead, EE, Semple, SJ, et al. Adverse drug events and medication errors in Australia. Int J Qual Health Care 2003; (15 Suppl. 1): i49–i59.
Google Scholar | Crossref | Medline39. Howard, RL, Avery, AJ, Slavenburg, S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007; 63: 136–147.
Google Scholar | Crossref | Medline | ISI40. Al Hamid, A, Ghaleb, M, Aljadhey, H, et al. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol 2014; 78: 202–217.
Google Scholar | Crossref | Medline | ISI41. Alhawassi, TM, Krass, I, Bajorek, BV, et al. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging 2014; 9: 2079–2086.
Google Scholar | Medline | ISI42. Oscanoa, TJ, Lizaraso, F, Carvajal, A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol 2017; 73: 759–770.
Google Scholar | Crossref | Medline43. Roughead, EE, Gilbert, AL, Primrose, JG, et al. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 1998; 168: 405–408.
Google Scholar | Crossref | Medline | ISI44. Wiffen, P, Gill, M, Edwards, J, et al. Adverse drug reactions in hospital patients: a systematic review of the prospective and retrospective studies. In: Database of Abstracts of Reviews of Effects (DARE): quality-assessed reviews. York, UK: Centre for Reviews and Dissemination (UK), 2002, pp.1–14.
Google Scholar45. Angamo, MT, Chalmers, L, Curtain, CM, et al. Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf 2016; 39: 847–857.
Google Scholar | Crossref | Medline46. Larmour, I, Dolphin, RG, Baxter, H, et al. A prospective study of hospital admissions due to drug reactions. Aust J Hosp Pharm 1991; 21: 90–95.
Google Scholar47. Stanton, LA, Peterson, GM, Rumble, RH, et al. Drug-related admissions to an Australian hospital. J Clin Pharm Ther 1994; 19: 341–347.
Google Scholar | Crossref | Medline | ISI48. Nelson, KM, Talbert, RL. Drug-related hospital admissions. Pharmacotherapy 1996; 16: 701–707.
Google Scholar | Medline | ISI49. Jha, AK, Kuperman, GJ, Rittenberg, E, et al. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001; 10: 113.
Google Scholar | Crossref | Medline | ISI50. Burgess, CL, Holman, CD, Satti, AG. Adverse drug reactions in older Australians, 1981-2002. Med J Aust 2005; 182: 267–270.
Google Scholar | Crossref | Medline | ISI51. Passarelli, MC, Jacob-Filho, W, Figueras, A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767–777. 2005/09/15. DOI: 10.2165/00002512-200522090-00005
Google Scholar | Crossref | Medline | ISI52. Budnitz, DS, Pollock, DA, Weidenbach, KN, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006; 296: 1858–1866.
Google Scholar | Crossref | Medline | ISI53.